The byr4 gene in Schizosaccharomyces pombe (fission yeast) encodes a critical regulator of cytokinesis, a process essential for cell division. Byr4 functions as a dosage-dependent inhibitor of the Septation Initiation Network (SIN), ensuring proper coordination between nuclear division (karyokinesis) and cytoplasmic division. Overexpression of Byr4 disrupts cytokinesis, leading to multinucleate cells, while null mutations cause cell cycle arrest with multiple septa formation .
The Byr4 antibody is a research tool used to detect and study the protein’s expression, localization, and post-translational modifications (e.g., phosphorylation) in yeast cells. Its development involves recombinant protein production in E. coli and purification via affinity chromatography, followed by immunization in rabbits to generate polyclonal antibodies .
Production Method:
Byr4 protein is expressed in E. coli as a His-tagged fusion, purified under denaturing conditions, and used to immunize rabbits. The resulting antiserum is affinity-purified using immobilized Byr4 protein .
Applications:
Validation:
The antibody’s specificity is confirmed by:
Byr4 regulates SIN activity through a small GTPase pathway involving Cdc16 (GAP), Spg1 (GTPase), and Cdc7 (effector) . Genetic suppression assays reveal that Byr4 functions downstream of Cdc16 and upstream of Cdc7 .
Cdk1 (a cyclin-dependent kinase) phosphorylates Byr4 at six in vivo sites (S248, S326, T429, S499, T502, S533), which modulates its SPB localization and SIN inhibition . A phosphomutant (byr4(7A)) lacking these sites exhibits hyperactive SIN inhibition, causing cytokinetic defects (e.g., binucleate cells) .
Phosphorylation Analysis:
Western blotting with the Byr4 antibody detects reduced mobility shifts in byr4(7A) mutants, confirming loss of Cdk1-mediated phosphorylation .
Protein-Protein Interactions:
Co-immunoprecipitation experiments show Byr4 interacts with Cdc16 and Spg1, critical for SIN regulation .
| Genotype | Phenotype | Frequency |
|---|---|---|
| Wild-type | Normal cytokinesis | 95% |
| byr4(7A) | Binucleate/multinucleate cells | 80% |
| byr4-null | Multiple septa, “cut” cells | 70% |
KEGG: spo:SPAC222.10c
STRING: 4896.SPAC222.10c.1
Byr4 is an essential gene in Schizosaccharomyces pombe (fission yeast) that functions as a dosage-dependent regulator of cytokinesis. Null alleles cause cell cycle arrest in late mitosis and permit multiple rounds of septation, while overexpression inhibits cytokinesis but allows cell cycle progression, leading to multinucleate cells . Byr4 plays a critical role in coordinating karyokinesis and cytokinesis by interacting with the septation initiation network (SIN) pathway . This makes it a valuable target for studying fundamental mechanisms of cell division regulation. The protein shows genetic interactions with the ras1 signaling pathways, suggesting broader roles in cellular signaling beyond cytokinesis .
Byr4 interacts directly with multiple components of the small GTPase pathway regulating cytokinesis in S. pombe. Specifically, both genetic suppression analyses and yeast two-hybrid assays demonstrate that Byr4 interacts with Cdc16 and Spg1 . The relationship between these proteins forms part of a regulatory cascade where Cdc16 functions as a GTPase activating protein (GAP), Spg1 as a GTPase, and Cdc7 as a downstream effector . Genetic interaction studies indicate that byr4 functions at the same level with or downstream of cdc16 and upstream of cdc7, forming a critical regulatory axis for cytokinesis timing .
The effects of byr4 perturbation exhibit clear dosage-dependency with distinct phenotypes:
| byr4 Condition | Cellular Phenotype | Nuclear Effects | Cytoskeletal Impact |
|---|---|---|---|
| Null mutation | Cell cycle arrest in late mitosis | Unequal DAPI staining between nuclei | Multiple rounds of septation |
| Overexpression | Inhibition of cytokinesis | Multinucleate cells | Normal F-actin ring formation but inhibition of ring contraction and septation |
| Interaction with ras1 null | Exacerbated inhibition of cytokinesis | Not specified | Suggests link between cell polarity and cytokinesis pathways |
These opposing phenotypes highlight byr4's crucial role as a dosage-dependent coordinator of key cell division processes .
Validation of byr4 antibodies requires thorough assaying for both sensitivity and specificity before use in research applications. The validation process should include testing against diverse complex biological samples rather than relying solely on purified recombinant proteins . At minimum, antibody specificity should be confirmed by the presence of a single band at the expected molecular weight in Western blots of complex biological samples . For byr4 specifically, this would involve:
Testing against wild-type S. pombe lysates
Including proper negative controls (e.g., byr4 deletion strains where viable)
Comparing electrophoretic mobility shifts in lysates from strains with mutations in interacting proteins like cdc16 and cdc15
Testing in multiple experimental contexts to ensure consistent results
This validation is critical when studying proteins like byr4 where phosphorylation states affect mobility and potentially epitope accessibility .
Detecting different phosphorylation states of byr4 requires careful optimization of Western blotting protocols, as the electrophoretic mobility of byr4 varies in response to mutations in genes that affect cytokinesis and karyokinesis . Researchers should consider:
Using phosphatase treatments as controls to confirm phosphorylation-dependent mobility shifts
Employing Phos-tag™ or similar phosphate-binding acrylamide gels to enhance separation of phosphorylated species
Optimizing running conditions (lower voltage, longer run times) to resolve closely migrating phosphorylated forms
Including lysates from strains with mutations known to affect byr4 phosphorylation, such as cdc16 (which produces a more rapidly migrating byr4) and β-tubulin mutants (which produce slower migrating byr4)
Using antibodies that recognize specific phosphorylated residues if available, particularly those targeted by Cdk1
These approaches help investigate how phosphorylation regulates byr4's role in cytokinesis coordination.
When designing immunofluorescence experiments with byr4 antibodies, several essential controls must be included to ensure valid and interpretable results:
Specificity controls: Include samples lacking byr4 expression or with reduced expression
Secondary antibody-only controls: To detect non-specific binding
Competing peptide controls: Pre-incubation of antibody with immunizing peptide should abolish specific signal
Co-localization controls: Include markers for structures where byr4 is expected to localize (e.g., spindle pole bodies during cell division)
Cell cycle synchronization: Since byr4 localization changes during the cell cycle, properly synchronized cells are crucial for comparative analyses
Fixation method validation: Test multiple fixation protocols as they may differentially affect epitope accessibility
These controls are particularly important given byr4's dynamic localization changes throughout the cell cycle .
Investigating the relationship between Cdk1 and byr4 phosphorylation requires sophisticated experimental approaches:
In vitro kinase assays: Using recombinant byr4 and purified Cdk1 (Cdc2-Cdc13), researchers can directly assess phosphorylation, as demonstrated in previous studies .
Phosphosite mapping: Mass spectrometry following in vitro kinase reactions or immunoprecipitation from cells can identify specific residues phosphorylated by Cdk1.
Phosphosite-specific antibodies: Development of antibodies against known Cdk1 phosphorylation sites on byr4 would allow monitoring of specific phosphorylation events in vivo.
Genetic approaches: Using temperature-sensitive cdk1 mutants or chemical inhibitors of Cdk1 to analyze byr4 phosphorylation status.
Phosphomimetic/phosphodeficient mutants: Creating byr4 variants where potential Cdk1 target sites are mutated to either mimic (S/T→D/E) or prevent (S/T→A) phosphorylation.
These approaches would clarify how Cdk1 activity influences byr4 function in coordinating cytokinesis with other cell cycle events .
Multiple complementary techniques are effective for studying interactions between byr4 and septation initiation network components:
Yeast two-hybrid assays: These have successfully demonstrated interactions between Byr4 and both Cdc16 and Spg1 .
Co-immunoprecipitation: Antibodies against byr4 can be used to pull down protein complexes from cell lysates, followed by Western blotting for potential interacting partners.
Bimolecular fluorescence complementation (BiFC): By tagging byr4 and potential interactors with complementary fragments of a fluorescent protein, interactions can be visualized in living cells.
Genetic suppression analyses: Testing whether altered expression of byr4 can suppress phenotypes of mutations in other SIN pathway genes, similar to how byr4 and cdc7 expression can suppress temperature-sensitive cdc16 mutations .
Proximity-dependent labeling: Techniques like BioID or APEX tagging of byr4 can identify proteins in close proximity in vivo.
These approaches provide complementary evidence for physical and functional interactions within the SIN pathway .
Computational approaches can significantly improve byr4 antibody specificity by applying methods similar to those used in recent antibody engineering studies:
Binding mode identification: Computational models can identify distinct binding modes associated with specific ligands, allowing prediction of antibody variants with enhanced specificity profiles .
Biophysics-informed modeling: Training models on experimentally selected antibodies can enable prediction and generation of specific variants beyond those observed in experiments .
Epitope mapping: Computational prediction of byr4 epitopes can guide antibody design toward regions of high specificity.
Cross-reactivity prediction: Models can predict potential cross-reactivity with related proteins, allowing researchers to select antibodies with the desired specificity profile.
Energy function optimization: For designing specific antibodies, computational approaches can minimize binding energy functions for desired interactions while maximizing those for undesired interactions .
These computational approaches complement experimental selection methods and enable the design of antibodies with customized specificity profiles for byr4 research .
Several factors may contribute to unexpected binding patterns when using byr4 antibodies:
Post-translational modifications: The electrophoretic mobility of byr4 protein varies depending on phosphorylation state, which changes throughout the cell cycle and in response to mutations in genes like cdc16, cdc15, and β-tubulin .
Sample preparation: Insufficient denaturation or inappropriate buffer conditions may affect epitope exposure and result in aberrant binding.
Strain-specific variations: Different yeast strains may express varying levels of byr4 or have slight sequence variations affecting antibody recognition.
Protein degradation: Since byr4 levels are tightly regulated, degradation products may appear as additional bands if protease inhibitors are inadequate.
Cross-reactivity: Antibodies may recognize proteins with similar epitopes, particularly in complex samples.
Cell synchronization: Since byr4 phosphorylation changes throughout the cell cycle, asynchronous cultures will show heterogeneous byr4 states .
Understanding these factors is crucial for interpreting byr4 Western blot results, particularly when studying phosphorylation dynamics.
Distinguishing specific from non-specific signals in byr4 immunofluorescence requires systematic validation:
Peptide competition: Pre-incubating the antibody with excess immunizing peptide should eliminate specific signals but not non-specific binding.
Genetic controls: Using strains with altered byr4 expression (deletion where viable, depletion, or overexpression) helps confirm signal specificity.
Multiple antibodies: Testing different antibodies targeting distinct byr4 epitopes should produce overlapping localization patterns if specific.
Signal correlation with cell cycle: Since byr4 localization changes during the cell cycle, specific signal should show predictable patterns in relation to cell cycle markers .
Co-localization studies: Comparing byr4 localization with known interacting partners (e.g., Cdc16, Spg1) provides additional validation .
Signal intensity quantification: Comparing signal intensities across cell populations and correlating with known biological variables helps distinguish random background from specific signal.
These approaches ensure reliable interpretation of byr4 localization data in immunofluorescence experiments.
When faced with contradictory results in byr4 antibody experiments, researchers should consider:
Antibody validation breadth: Extensively validate antibodies using diverse complex biological samples rather than just purified proteins .
Multiple detection methods: Combine different techniques (Western blot, immunofluorescence, immunoprecipitation) to build a consistent picture.
Controls for phosphorylation state: Since byr4 phosphorylation state affects its properties, include controls treating samples with phosphatases or using synchronized cells .
Genetic complementation: Test whether phenotypes can be rescued by wild-type byr4 expression to confirm specificity.
Quantitative analysis: Move beyond qualitative assessment to quantitative measurements with appropriate statistical analysis.
Independent antibody sources: Test antibodies from different sources or raised against different epitopes.
Strain background effects: Consider how genetic background may influence byr4 behavior and antibody recognition.
Byr4 antibodies can help elucidate the connection between cell polarity and cytokinesis in several ways:
Co-localization studies: Examining byr4 localization relative to cell polarity markers across the cell cycle.
Genetic interaction analysis: Using byr4 antibodies to examine protein levels and modifications in strains with mutations in polarity genes like ras1 and scd1, which exacerbate byr4 overexpression phenotypes .
Phosphorylation dynamics: Investigating how disruption of polarity pathways affects byr4 phosphorylation patterns.
Cytoskeletal interactions: Examining how byr4 influences F-actin ring formation and contraction in different genetic backgrounds .
Temporal coordination studies: Using time-lapse microscopy with immunofluorescence to track byr4 dynamics relative to polarity establishment and cytokinesis events.
These approaches would clarify byr4's role in connecting polarity cues to cytokinesis execution, a relationship suggested by genetic interactions but not fully characterized mechanistically .
Detecting transient byr4 phosphorylation events requires cutting-edge methodologies:
Live-cell phospho-sensors: Engineering FRET-based sensors that detect specific phosphorylation events on byr4 in real-time.
Single-cell proteomics: Applying emerging single-cell phosphoproteomics techniques to capture cell-to-cell variation in byr4 phosphorylation.
Targeted mass spectrometry: Using selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) for highly sensitive detection of specific phosphopeptides.
Rapid kinetics approaches: Developing methods for ultra-rapid cell fixation to capture short-lived phosphorylation states.
Phospho-specific antibodies: Generating antibodies against specific predicted Cdk1 phosphorylation sites on byr4 .
Chemical genetics: Using analog-sensitive kinase mutants to precisely control and monitor byr4 phosphorylation timing.
These approaches would provide unprecedented temporal resolution of byr4 phosphorylation dynamics during the cell cycle.
Systems biology approaches offer powerful frameworks to contextualize byr4 within broader networks:
Quantitative proteomics: Using byr4 antibodies for immunoprecipitation followed by mass spectrometry to identify interaction partners under different conditions.
Dynamic modeling: Developing mathematical models incorporating byr4 phosphorylation data to predict system-level responses to perturbations.
Multi-omics integration: Combining antibody-based proteomics data with transcriptomics and metabolomics to build comprehensive regulatory networks.
Network analysis: Mapping byr4's position within the broader cell cycle control network using protein-protein interaction data.
Comparative analysis: Using byr4 antibodies across related yeast species to identify evolutionary conservation and divergence in regulatory networks.
Synthetic biology approaches: Reconstructing minimal systems containing byr4 and key interactors to test sufficiency for specific functions.
These approaches would transform isolated byr4 antibody data into system-level understanding of cell cycle regulation mechanisms.